Rafael Medrano-Guzman
Overview
Explore the profile of Rafael Medrano-Guzman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
339
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De la Cerda-Vargas M, Pantalone M, Soderberg Naucler C, Medrano-Guzman R, Jauregui Renaud K, Nettel Rueda B, et al.
Heliyon
. 2024 Apr;
10(7):e28555.
PMID: 38623248
Introduction: Previous studies have reported a correlation between a high-grade CMV-infection and an unfavorable prognosis in glioblastoma (GB). Coversely, epilepsy has been associated with a more favorable outcome in GB...
2.
Medrano-Guzman R, Brener-Chaoul M, Garcia-Rios L, Luna-Castillo M
Cir Cir
. 2022 Nov;
91(6):810-815.
PMID: 36423355
Objective: To define the impact of surgical margins on local recurrence (LR), distant recurrence (DR) and overall survival (OS) in patients with soft tissue sarcomas of the extremities (eSTS). Method:...
3.
Sanchez-Ramirez D, Medrano-Guzman R, Candanedo-Gonzalez F, de Anda-Gonzalez J, Garcia-Rios L, Perez-Koldenkova V, et al.
Eur J Histochem
. 2022 Feb;
66(1).
PMID: 35174683
Desmoplastic stroma (DS) and the epithelial-to-mesenchymal transition (EMT) play a key role in pancreatic ductal adenocarcinoma (PDAC) progression. To date, however, the combined expression of DS and EMT markers, and...
4.
Garcia-Rios L, Garcia-Avila A, Luna-Castillo M, Anda-Gonzalez J, Medrano-Guzman R
Ann Hepatobiliary Pancreat Surg
. 2021 Nov;
25(4):544-550.
PMID: 34845129
Germ cell tumors (GCTs) are considered as extragonadal if there is no evidence of a primary tumor in the testes or ovaries. GCTs can be classified as seminomas, non-seminomatous, mature...
5.
Medrano-Guzman R, Luna-Castillo M, Chable-Puc W, Garcia-Rios L, Gonzalez-Rodriguez D, Najera-Dominguez F
Cir Cir
. 2019 Jan;
87(1):69-78.
PMID: 30600816
Introduction: Pancreatic tumors and periampullary tumors have a similar clinical presentation; pancreatoduodenectomy represents the only possibility of cure or of increasing survival; with an average mortality of 5-10% and a...
6.
Sanchez-Garcia J, Candanedo-Gonzalez F, Felix-Felix A, Sanchez-Ramirez D, Medrano-Guzman R, Quintana-Quintana M, et al.
Ann Med Surg (Lond)
. 2018 May;
30:7-12.
PMID: 29707208
Introduction: Pancreatic ductal adenocarcinoma (PDAC) and ampulla of Vater adenocarcinomas (AVAC) are periampullary tumors. These tumors have overlapping symptoms and a common treatment, but present differences in their survival and...
7.
Sanchez-Zauco N, Torres J, Gomez A, Camorlinga-Ponce M, Munoz-Perez L, Herrera-Goepfert R, et al.
BMC Cancer
. 2017 Oct;
17(1):669.
PMID: 28969609
No abstract available.
8.
Yu G, Torres J, Hu N, Medrano-Guzman R, Herrera-Goepfert R, Humphrys M, et al.
Front Cell Infect Microbiol
. 2017 Jul;
7:302.
PMID: 28730144
() is the primary cause of gastric cancer but we know little of its relative abundance and other microbes in the stomach, especially at the time of gastric cancer diagnosis....
9.
Sanchez-Zauco N, Torres J, Gomez A, Camorlinga-Ponce M, Munoz-Perez L, Herrera-Goepfert R, et al.
BMC Cancer
. 2017 Jun;
17(1):384.
PMID: 28558708
Background: Gastric adenocarcinoma is the third most common cause of cancer-associated death worldwide. Helicobacter pylori infection activates a signaling cascade that induces production of cytokines and chemokines involved in the...
10.
Alvarado-Cabrero I, Gil-Hernandez S, Ruelas-Perea A, Villaverde-Rodriguez D, Montes-Ochoa J, Medrano-Guzman R
Cir Cir
. 2017 Jan;
85(6):504-509.
PMID: 28069112
Background: Gastric cancer in Mexico is ranked third in both males and females. Most patients present clinically with advanced disease and treatment options are sparse. HER2 overexpression in gastric cancer...